Brief Type: Advocacy Letter
Medicare Part D/IRA PAWH Implications Comments
July 3, 2025Comments to the HHS Office of Intergovernmental and External Affairs regarding implementation considerations for Medicare Part D and the Inflation Reduction Act (IRA) for people aging with HIV (PAWH).
Senate HELP Committee Leadership PBM Reform Comments
Comments to the leadership of the US Senate Health, Education, Labor, and Pensions (HELP) Committee regarding proposed reforms to the Pharmacy Benefit Manager (PBM) system.
Stakeholder Comment on Odefsey Affordability Review – HIV Access and Systems Considerations
Comments on the Oregon Prescription Drug Affordability Board’s affordability review of Odefsey.
Letter to Senate Leadership on the Pasteur Act
September 11, 2024Co-signed letter to the leadership of the US Senate regarding the introduced Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act.
Oregon Health Authority Medicaid Waiver Comments
July 3, 2024Comments on proposed formulary changes to Oregon’s Medicaid program to the Oregon Health Authority.
HHS Section 504 QALYs Comments
November 13, 2023Comments on proposed revisions to the Older Americans Act in the context of Section 504 of the Rehabilitation Act and concerns regarding quality-adjusted life-years (QALYs).
Older Americans Act Comments
August 15, 2023Comments on proposed revisions to the Older Americans Act regarding LGBTQI+ community and other considerations.
Main Menu
Additional Resources
© Copyright 2025 National Coalition for LGBTQ Health. All rights reserved. | Privacy Policy | Site Map